302 related articles for article (PubMed ID: 16449115)
1. Association between low day 16 hCG and miscarriage after proven cardiac activity.
Tong S; Wallace EM; Rombauts L
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):300-4. PubMed ID: 16449115
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies.
Gracia CR; Sammel MD; Chittams J; Hummel AC; Shaunik A; Barnhart KT
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):993-9. PubMed ID: 16260517
[TBL] [Abstract][Full Text] [Related]
3. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the prognosis of in vitro fertilization pregnancies with initially low serum human chorionic gonadotropin levels.
Frishman GN; Hackett RJ; McGrath M; Metheny WP
Am J Obstet Gynecol; 2001 Aug; 185(2):392-5. PubMed ID: 11518898
[TBL] [Abstract][Full Text] [Related]
5. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve.
Barnhart K; Sammel MD; Chung K; Zhou L; Hummel AC; Guo W
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):975-81. PubMed ID: 15516387
[TBL] [Abstract][Full Text] [Related]
6. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of maternal serum macrophage inhibitory cytokine-1 and pregnancy-associated plasma protein-A at 6-10 weeks of gestation to predict miscarriage.
Tong S; Ngian GL; Onwude JL; Permezel M; Saglam B; Hay S; Konje JC; Marczylo TH; Fleming G; Walker SP; Lappas M
Obstet Gynecol; 2012 May; 119(5):1000-8. PubMed ID: 22525911
[TBL] [Abstract][Full Text] [Related]
8. Miscarriage risk for asymptomatic women after a normal first-trimester prenatal visit.
Tong S; Kaur A; Walker SP; Bryant V; Onwude JL; Permezel M
Obstet Gynecol; 2008 Mar; 111(3):710-4. PubMed ID: 18310375
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
10. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
11. Rate of spontaneous abortion after first trimester sonographic demonstration of fetal cardiac activity.
Siddiqi TA; Caligaris JT; Miodovnik M; Holroyde JC; Mimouni F
Am J Perinatol; 1988 Jan; 5(1):1-4. PubMed ID: 3276331
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.
Steier JA; Bergsjø P; Myking OL
Obstet Gynecol; 1984 Sep; 64(3):391-4. PubMed ID: 6462569
[TBL] [Abstract][Full Text] [Related]
13. Vaginal sonography findings and hCG dynamics of early intrauterine and tubal pregnancies.
Bateman BG; Nunley WC; Kolp LA; Kitchin JD; Felder R
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):421-7. PubMed ID: 2406662
[TBL] [Abstract][Full Text] [Related]
14. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening.
Towner D; Currier RJ; Lorey FW; Cunningham GC; Greve LC
Am J Obstet Gynecol; 2007 Jun; 196(6):608.e1-5; discussion 608.e5. PubMed ID: 17547917
[TBL] [Abstract][Full Text] [Related]
15. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
17. Incidence of early loss of pregnancy.
Wilcox AJ; Weinberg CR; O'Connor JF; Baird DD; Schlatterer JP; Canfield RE; Armstrong EG; Nisula BC
N Engl J Med; 1988 Jul; 319(4):189-94. PubMed ID: 3393170
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
19. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures.
Sasaki Y; Ladner DG; Cole LA
Fertil Steril; 2008 Jun; 89(6):1781-6. PubMed ID: 17675003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
